Sign in

You're signed outSign in or to get full access.

Anthony Puntillo

Vice-Chairman of the Board at Finward Bancorp
Board

About Anthony M. Puntillo

Anthony M. Puntillo, D.D.S., M.S.D., is an orthodontist who founded Puntillo & Crane Orthodontics, PC (multi‑location practice in Northwest Indiana) in 1994 and serves as co‑owner and senior partner; he is a Class III director (term to 2027), age 57, and has served on FNWD’s board since 2004 . He previously served as Lead Independent Director from March 2022 to February 2024; he currently serves as Vice‑Chairman of the Board and Executive Committee, Vice‑Chairman of the Audit Committee, and Chair of the Nominating & Corporate Governance Committee . He also serves as a Director of the American Board of Orthodontics, is a past President of the Great Lakes Association of Orthodontists, and is active in the Bank’s communities .

Past Roles

OrganizationRoleTenureCommittees/Impact
Finward BancorpLead Independent DirectorFeb 2022 – Feb 2024Chaired executive sessions; helped develop Board agendas; coordinated director recruitment and shareholder communications
Finward BancorpVice‑Chairman of Board & Executive Committee2022 – presentExecutive Committee Vice Chair; strategic leadership; continuity across leadership transition
Finward BancorpChair, Strategic Planning Committee2021Led long‑term planning; also member of Compensation & Benefits, Executive, Risk Management & Audit
Finward BancorpMember, Compensation & Benefits Committee2022Oversight of executive and director pay; advisor‑supported benchmarking
Finward BancorpMember, Nominating & Corporate Governance Committee2022 – presentBoard composition, governance policies; stock ownership guidelines oversight
Finward BancorpVice‑Chairman, Audit Committee2025Financial reporting and internal control oversight

External Roles

OrganizationRoleTenureCommittees/Impact
American Board of OrthodonticsDirectorOngoingGovernance in professional certification; sector expertise
Great Lakes Association of OrthodontistsPast PresidentPrior serviceRegional professional leadership; network breadth
Various orthodontics associationsMemberOngoingProfessional engagement; reputation and community ties

Board Governance

  • Independence: Served as Lead Independent Director (Mar 2022–Feb 2024); FNWD’s Audit, Risk Management & Compliance, Nominating & Corporate Governance, and Compensation & Benefits Committees are comprised solely of independent directors .
  • Current committee leadership: Vice‑Chairman, Audit Committee; Chair, Nominating & Corporate Governance; Vice‑Chairman, Executive Committee .
  • Attendance and engagement: No director attended fewer than 80% of Board and committee meetings in 2021, 2022, or 2023; all directors attended the Annual Meeting on May 24, 2024 .
  • Director compensation policy: Annual cash retainer $28,500; Lead Independent Director retainer $12,000; chair retainers—Risk Management & Compliance $3,500; Compensation & Benefits $3,000; other committees $2,500; Credit Committee members (non‑chair) $500; equity awards may be granted at ~$11,000 and vest immediately; 2024 directors received no equity awards .
  • Deferred compensation: Directors can defer fees under the Post‑2004 Unfunded Deferred Compensation Plan; interest basis updated to the 2‑year U.S. Treasury Bill rate (reset monthly); prior framework referenced 6‑month CD +2% or 120% AFR .

Fixed Compensation

Metric202220232024
Fees Earned or Paid in Cash ($)$37,333 $41,750 $34,000
All Other Compensation ($) – Medical benefit paid by Bank$19,232 $21,450 $16,058
Total ($)$67,548 $74,200 $50,058

Performance Compensation

YearStock Awards ($)Grant DateShares GrantedGrant PriceVesting
2022$10,983 Feb 11, 2022 229 $47.96 Fully vested on grant
2023$11,000 Feb 6, 2023 299 $36.73 Fully vested on grant
2024$0 (no equity awards to directors)
  • Historical service‑based equity: In 2020, directors received restricted stock for committee chair roles and attendance above four meetings; Dr. Puntillo received 141 shares with grant‑date fair value $5,711 .
  • Stock ownership and holding: Directors must hold 100% of shares for at least one year post‑vesting and retain 75% of net shares until meeting ownership guidelines; minimum ownership for non‑employee directors is $100,000 in market value, with five‑year compliance window .

Other Directorships & Interlocks

Company/OrganizationTypeRoleCommittee/Notes
American Board of OrthodonticsNon‑profit/professionalDirectorProfessional certification governance
Great Lakes Association of OrthodontistsProfessional associationPast PresidentRegional leadership
Orthodontics associations (various)Professional associationsMemberOngoing engagement

No public company directorships or disclosed interlocks with FNWD competitors/suppliers/customers are cited in the referenced proxies .

Expertise & Qualifications

  • D.D.S., M.S.D.; founder and co‑owner of a multi‑location orthodontics practice since 1994; adds small business profile relevant to business lending strategies .
  • Governance experience as Lead Independent Director, Vice‑Chair roles, and chair of Nominating & Corporate Governance; participant in compensation oversight .
  • Active community engagement within the Bank’s markets, supporting FNWD’s community banking model .

Equity Ownership

DateBeneficially Owned SharesPercent of ClassUnvested Restricted Shares
Mar 3, 20234,788 * (under 1% per footnote) 447 (as of Dec 31, 2022)
Mar 22, 20244,833 *253 (as of Dec 31, 2023)
  • Stock ownership guidelines: Non‑employee directors must hold at least $100,000 in market value; 1‑year post‑vesting hold and 75% net‑share retention until compliant; five‑year window to achieve threshold .

Governance Assessment

  • Board effectiveness: Long‑tenured independent director with sustained leadership (Lead Independent through Feb 2024; Vice‑Chair roles; committee chairmanship), reinforcing oversight continuity and independent challenge .
  • Alignment and incentives: Director pay structure emphasizes modest cash retainers and small, immediately‑vested equity grants (~$11k in 2022–2023) with stringent post‑vesting holding and ownership guidelines; directors received no equity grants in 2024, indicating restraint amidst performance conditions .
  • Engagement: Consistent attendance above 80% and full Annual Meeting participation, supporting investor confidence in governance diligence .
  • Perquisites: Notable medical benefit amounts ($19,232 in 2022; $21,450 in 2023; $16,058 in 2024) are disclosed and transparent; fee deferral program uses a market‑based interest benchmark (2‑year U.S. Treasury), reducing preferential treatment risk .

Signals/Watch‑Items

  • Leadership concentration is balanced by independent committee composition; continued monitoring of role changes (e.g., Audit Committee vice‑chairmanship) is prudent for oversight quality .
  • External business ownership in local markets adds valuable small‑business perspective; maintain watch for any related‑party transactions in future filings (none surfaced in cited excerpts) .